
1. plos one. 2014 jul 3;9(7):e101783. doi: 10.1371/journal.pone.0101783. ecollection
2014.

variation circumsporozoite protein plasmodium falciparum: vaccine
development implications.

gandhi k(1), thera ma(2), coulibaly d(2), traor√© k(2), guindo ab(2), ouattara
a(1), takala-harrison s(1), berry aa(1), doumbo ok(2), plowe cv(1).

author information: 
(1)howard hughes medical institute/center vaccine development, university 
maryland school medicine, baltimore, maryland, united states america.
(2)malaria research training center, university science, techniques and
technology, bamako, mali.

erratum in
    plos one. 2016;11(1):e0148240.

the malaria vaccine candidate rts,s/as01 based immunogenic regions of
plasmodium falciparum circumsporozoite protein (csp) 3d7 reference
strain shown modest efficacy clinical disease african
children. remains unclear aspect(s) immune response elicited by
this vaccine protective. goals study measure diversity in
immunogenic regions csp, identify associations polymorphism 
csp risk p. falciparum infection clinical disease. present
study includes data samples prospective cohort study designed to
measure incidence malaria infection disease children bandiagara,
mali. total 769 parasite-positive blood samples corresponding acute 
clinical malaria episodes asymptomatic infections experienced 100 children
were included study. non-synonymous snp data generated 454
sequencing t-cell epitopes, repeat length data generated the
b-cell epitopes cs gene. cox proportional hazards models used to
determine effect sequence variation consecutive infections occurring
within individuals time new infection new clinical malaria episode.
diversity t-cell epitope-encoding regions th2r th3r remained stable
throughout seasons, age groups clinical asymptomatic
infections exception higher proportion 3d7 haplotypes found in
the oldest age group. associations sequence variation hazard of
infection clinical malaria detected. lack association between
sequence variation hazard infection clinical malaria suggests that
naturally acquired immunity csp may allele-specific.

doi: 10.1371/journal.pone.0101783 
pmcid: pmc4081809
pmid: 24992338  [indexed medline]

